Vical grants additional academic licenses on DNA delivery technology to research institutions (PharmaBiz)
Vical grants additional academic licenses on DNA delivery technology to research institutions (PharmaBiz)
Vical Incorporated has granted non-exclusive, academic licenses for its broad DNA delivery technology patent estate to six additional leading research institutions Fred Hutchinson Cancer Research Centre, Texas Tech University Health Sciences Centre, University of Iowa, University of Notre Dame, University of Pittsburgh, and University of Washington.